Allergan, Inc. (NYSE:AGN): Jeffrey Altman, Mark Kingdon, and Tom Sandell Showing Some LoveBy Ryan WallaceNovember 17, 2014 Is Allergan, Inc. (NYSE:AGN) the right pick for your portfolio? Prominent investors are getting less optimistic. The number of bullish…